Wasman Jane

Rigel Pharmaceuticals, Inc. · Director

Wasman Jane is listed in public filings as director. This Wasman Jane insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Rigel Pharmaceuticals, Inc. (RIGL), and SELLAS Life Sciences Group, Inc. (SLS). Investors use Wasman Jane's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
SELLAS Life Sciences Group, Inc.SLS$34k20k sharesBuyMay 30, 2025$1.69--